Central Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.35 Cr
- Paid Up Capital ₹ 3.33 Cr
- Company Age 17 Year, 19 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.52 Cr
- Revenue Growth 5.52%
- Profit Growth -5.19%
- Ebitda 12.31%
- Net Worth 93.89%
- Total Assets -3.18%
About Central Biotech
Central Biotech Private Limited (CBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 January 2008 and has a history of 17 years. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.35 Cr and a paid-up capital of Rs 3.33 Cr.
The company currently has active open charges totaling ₹5.52 Cr.
Pravin Rasekar, Liladhar Mahajan, Harish Rameshrao, and Four other members serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999MH2008PTC178123
-
Company No.
178123
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jan 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Central Biotech Private Limited offer?
Central Biotech Private Limited offers a wide range of products and services, including Insecticides, Organic Pesticides, Fungicides, Organic Fungicide, Plant Growth Promoters, Plant Nutrient, Fertilizer, Micronutrient, Nitrogen Fertilizers, NPK Fertilizer.
Who are the key members and board of directors at Central Biotech?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravin Rasekar
|
Director | 10-Feb-2012 | Current |
|
Liladhar Mahajan
|
Director | 10-Feb-2012 | Current |
|
Harish Rameshrao
|
Director | 10-Feb-2012 | Current |
|
Dnyaneshwar Shingarwade
|
Director | 10-Feb-2012 | Current |
|
Chandrashekhar Dhawad
|
Director | 10-Feb-2012 | Current |
|
Prashant Resekar
|
Director | 22-Jan-2008 | Current |
Financial Performance of Central Biotech.
Central Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.52% increase. The company also saw a slight decrease in profitability, with a 5.19% decrease in profit. The company's net worth Soared by an impressive increase of 93.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Central Biotech?
In 2023, Central Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
7 Wonders Buildcon LlpPravin Rasekar, Liladhar Mahajan and 5 more are mutual person
-
Encon Organic Private Limited
Pravin Rasekar, Liladhar Mahajan and 5 more are mutual person
-
Dhawad Trading Private Limited
Chandrashekhar Dhawad is a mutual person
-
Encon Polymers Private Limited
Prashant Resekar and Anil Rasekar are mutual person
Charges (Loans)
₹5.52 Cr
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 5.52 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2016 | Indian Overseas Bank | ₹5.52 Cr | Open |
How Many Employees Work at Central Biotech?
Central Biotech has a workforce of 69 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Central Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Central Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.